002773SZSE
🚨 Material Event

Announcement on Company's Provisional Selection in National Centralized Drug Procurement

✨ AI Summary

Chengdu Kanghong Pharmaceutical Group Co., Ltd. has been provisionally selected in the 12th batch of national centralized drug procurement for its Pirfenidone Tablets. This selection is expected to expand sales, enhance market share, and positively impact future business performance. The company will closely monitor subsequent contract signing and market execution.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Company Code: 002773 Company Short Name: Kanghong Pharmaceutical Announcement Number: 2026-045

Chengdu Kanghong Pharmaceutical Group Co., Ltd.

Announcement on Company's Provisional Selection in National Centralized Drug Procurement

The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed herein, without any false records, misleading statements, or significant omissions.

On July 31, 2026, the National Joint Procurement Office for Drug Procurement (hereinafter referred to as the "Procurement Office") released the "Provisional Selection Results Announcement for the 12th Batch of National Centralized Drug Procurement with Volume-Based Purchasing." Chengdu Kanghong Pharmaceutical Group Co., Ltd. (hereinafter referred to as the "Company" or "Kanghong Pharmaceutical")'s Pirfenidone Tablets were included in the "Provisional Selection Results Table for the 12th Batch of National Centralized Drug Procurement with Volume-Based Purchasing" (GY-YD2026-1) by the Procurement Office. The relevant situation is hereby announced as follows:

I. Provisional Selection Product Information

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.